AuB Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.05M

  • Investors
  • 6

AuB General Information

Description

Manufacturer of health products intended to provide nutrition and encourage fitness. The company offers supplements based on the research of microbiome and stool samples of athletes and also provides services like dietary improvement services based on the results of an athlete's intestinal flora data, enabling consumers and athletes to improve performance.

Contact Information

Website
www.aub.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sagami Building 2nd Floor
  • 7-13-6 Ginza, Chuo-ku
  • Tokyo, 104-0061
  • Japan
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
LOHAS & Wellness, Manufacturing, Artificial Intelligence & Machine Learning, E-Commerce, HealthTech
Corporate Office
  • Sagami Building 2nd Floor
  • 7-13-6 Ginza, Chuo-ku
  • Tokyo, 104-0061
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AuB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 22-Jul-2025 $2.05M Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Later Stage VC (Series B) 01-Jun-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Sep-2019 $2.8M $3.61M Completed Generating Revenue
1. Seed Round $807K $807K Completed Startup
To view AuB’s complete valuation and funding history, request access »

AuB Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class C
Class B
Class A 2,341,663 $0.82 $0.82 1x $0.82 18.46%
To view AuB’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AuB Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

AuB Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024067910-A Information providing apparatus, information providing system, and information providing method Pending 07-Nov-2022
WO-2024075811-A1 Intestinal information estimation system, intestinal information estimation method, control program, and recording medium Inactive 05-Oct-2022
JP-2023041305-A Information proposal device, information proposal system, and information proposal method Pending 13-Sep-2021
JP-6995411-B2 New bifidobacterium spp. and compositions containing them Active 18-Feb-2020
WO-2021166285-A1 Novel bacterium belonging to genus bifidobacterium and composition comprising same Inactive 18-Feb-2020 C12N1/205
To view AuB’s complete patent history, request access »

AuB Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AuB Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Septeni Holdings Holding Company Minority
Kyocera Corporation Minority
Shizuoka Capital Corporate Venture Capital Minority
Mitsubishi UFJ Capital Venture Capital Minority
Taisho Pharmaceutical Holding Company Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

AuB FAQs

  • When was AuB founded?

    AuB was founded in 2015.

  • Where is AuB headquartered?

    AuB is headquartered in Tokyo, Japan.

  • What is the size of AuB?

    AuB has 9 total employees.

  • What industry is AuB in?

    AuB’s primary industry is Pharmaceuticals.

  • Is AuB a private or public company?

    AuB is a Private company.

  • What is the current valuation of AuB?

    The current valuation of AuB is .

  • What is AuB’s current revenue?

    The current revenue for AuB is .

  • How much funding has AuB raised over time?

    AuB has raised $7.99M.

  • Who are AuB’s investors?

    Septeni Holdings, Kyocera, Shizuoka Capital, Mitsubishi UFJ Capital, and Taisho Pharmaceutical are 5 of 6 investors who have invested in AuB.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process